Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.720
-0.020 (-0.73%)
At close: Aug 21, 2026, 4:00 PM EDT
2.710
-0.010 (-0.37%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $121.89 million as of August 21, 2026. Its market cap has decreased by -2.85% in one year.
Market Cap
121.89M
Enterprise Value
105.64M
1-Year Change
-2.85%
Ranking
Category
Stock Price
$2.72
ChartMarket Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $121.89M, a decrease of -13.98%. That is a compound annual growth rate of -4.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 121.89M | -25.69% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cibus | 129.93M |
| Aardvark Therapeutics | 128.90M |
| Outlook Therapeutics | 126.47M |
| Inovio Pharmaceuticals | 125.11M |
| Black Diamond Therapeutics | 123.53M |
| Anixa Biosciences | 122.14M |
| Vivani Medical | 121.59M |
| Rani Therapeutics Holdings | 118.63M |